Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

391 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review.
Athyros VG, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP. Athyros VG, et al. Curr Med Res Opin. 2013 Oct;29(10):1263-74. doi: 10.1185/03007995.2013.827566. Epub 2013 Aug 8. Curr Med Res Opin. 2013. PMID: 23879722 Review.
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P, Athyros VG, Mikhailidis DP. Karagiannis A, et al. Expert Opin Pharmacother. 2008 Mar;9(4):509-15. doi: 10.1517/14656566.9.4.509. Expert Opin Pharmacother. 2008. PMID: 18312153 Clinical Trial.
After a 2-week washout period, 34 patients with IHA were assigned to receive either spironolactone 25 mg b.i.d. (n = 17) or eplerenone 25 mg b.i.d. ...If the patients' BP remained uncontrolled, a daily dose of hydrochlorothiazide 12.5 mg was added at week 16. The pr …
After a 2-week washout period, 34 patients with IHA were assigned to receive either spironolactone 25 mg b.i.d. (n = 17) or eplerenon …
Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Pagourelias ED, Koumaras C, Kakafika AI, Tziomalos K, Zorou PG, Athyros VG, Karagiannis A. Pagourelias ED, et al. Angiology. 2009 Feb-Mar;60(1):74-81. doi: 10.1177/0003319708316169. Epub 2008 Apr 14. Angiology. 2009. PMID: 18413330 Review.
Several factors play a role in the pathogenesis of anemia in CHF, including inflammation, impaired renal function, use of certain antihypertensive or cardioprotective agents, and gastrointestinal or urinary losses of essential hemopoietic factors. ...
Several factors play a role in the pathogenesis of anemia in CHF, including inflammation, impaired renal function, use of certain ant …
Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.
Doumas M, Papademetriou V, Athyros V, Karagiannis A. Doumas M, et al. Angiology. 2015 Nov;66(10):901-3. doi: 10.1177/0003319715594291. Epub 2015 Jul 10. Angiology. 2015. PMID: 26162400 No abstract available.
Cardiovascular Risk in Middle East Populations: A Call to Action.
Tziomalos K, Athyros VG, Karagiannis A. Tziomalos K, et al. Angiology. 2015 Oct;66(9):801-2. doi: 10.1177/0003319714557540. Epub 2014 Nov 17. Angiology. 2015. PMID: 25404714 No abstract available.
Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review.
Theocharidou E, Gossios TD, Giouleme O, Athyros VG, Karagiannis A. Theocharidou E, et al. Angiology. 2014 Apr;65(4):284-93. doi: 10.1177/0003319713477471. Epub 2013 Feb 18. Angiology. 2014. PMID: 23423851 Review.
A total of 6 studies met the inclusion criteria including 217 patients with Crohn's disease (CD) and 85 with ulcerative colitis (UC). ...
A total of 6 studies met the inclusion criteria including 217 patients with Crohn's disease (CD) and 85 with ulcerative colitis (UC).
Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data.
Theocharidou E, Gossios TD, Griva T, Giouleme O, Douma S, Athyros VG, Karagiannis A. Theocharidou E, et al. Angiology. 2014 Jul;65(6):543-50. doi: 10.1177/0003319713489876. Epub 2013 Jun 6. Angiology. 2014. PMID: 23748978
Inflammation is a predictor of cardiovascular disease (CVD). Thus, inflammatory bowel diseases (IBD) may be associated with CVD. ...Factors associated with cIMT were age, body mass index, and IBD, with the latter making a greater contribution. The IBD is a pr …
Inflammation is a predictor of cardiovascular disease (CVD). Thus, inflammatory bowel diseases (IBD) may be associated with CVD. ...F …
JUPITER: major implications for vascular risk assessment.
Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Tziomalos K, et al. Curr Med Res Opin. 2009 Jan;25(1):133-7. doi: 10.1185/03007990802643557. Curr Med Res Opin. 2009. PMID: 19210146
Psoriasis and Vascular Risk : An Update.
Katsiki N, Anagnostis P, Athyros VG, Karagiannis A, Mikhailidis DP. Katsiki N, et al. Curr Pharm Des. 2014;20(39):6114-25. doi: 10.2174/1381612820666140417105323. Curr Pharm Des. 2014. PMID: 24745923 Review.
Psoriasis is a chronic systemic inflammatory disease characterized by topical skin lesions as well as an increased risk for cardiovascular disease (CVD). ...
Psoriasis is a chronic systemic inflammatory disease characterized by topical skin lesions as well as an increased risk for cardiovas …
Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?
Imprialos KP, Boutari C, Stavropoulos K, Doumas M, Karagiannis AI. Imprialos KP, et al. J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):249-253. doi: 10.1136/jnnp-2016-314704. Epub 2016 Nov 28. J Neurol Neurosurg Psychiatry. 2017. PMID: 27895093 Review.
Sodium-glucose co-transporters 2 (SGLT-2) inhibitors have emerged as a novel antidiabetic class of drugs that exert favourable results in a variety of other cardiovascular risk factors too, such as increased blood pressure and body weight. ...Accumulating evidence s …
Sodium-glucose co-transporters 2 (SGLT-2) inhibitors have emerged as a novel antidiabetic class of drugs that exert favourable result …
391 results
Jump to page
Feedback